Herantis Pharma’s Manager’s Transactions

Herantis Pharma’s Manager’s Transactions

Herantis Pharma Plc
Company release 10 Nov 2017 at 9:00 am

Herantis Pharma Oyj – Managers’ Transactions

____________________________________________

Person subject to the notification requirement

Name: Mattila, Pekka

Position: Member of the Board/Deputy member

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20171109210453_4

____________________________________________

Transaction date: 2017-11-09

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: SUBSCRIPTION

Transaction Details

(1): Volume: 2500 Unit price: 5.85000 EUR

Aggregated transactions

(1): Volume: 2500 Volume weighted average price: 5.85000 EUR

____________________________________________

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 246

Distribution:

Nasdaq Helsinki
Main media
www.herantis.com